effects [qlco]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Acetate [orch, phsu]
Beta [plnt]
Norethisterone acetate [horm, phsu, strd]
Lipids [lipd]
Lipoproteins [aapp, bacs]
objectives [inpr]
Various [irda]
Estrogen [horm, phsu, strd]
Progestagen [horm, phsu, strd]
Combinations [mnob]
therapy, hormonal [topp]
Replacement [topp]
Reported [inpr]
Lipid [lipd]
Lipoprotein [aapp, bacs]
Fractions [qnco]
Comparative Study [inpr]
Continuous [idcn]
Combined [qlco]
regimens [inpr]
Sweden [geoa]
Study [mnob]
effects [qlco]
Lipid [lipd]
Profile [lbpr]
Methods [inpr]
prospective [resa]
Double-Blind Study [resa]
Post-Menopause [orgf]
Women [popg]
randomized [resa]
Conjugated estrogen [horm, phsu, strd]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
mg% [qnco]
17beta estradiol [horm, phsu, strd]
E2 [gngm]
mg% [qnco]
Norethisterone acetate [horm, phsu, strd]
mg% [qnco]
serum concentration [qnco]
Lipids [lipd]
Lipoproteins [aapp, bacs]
Measured [qlco]
baseline [bodm]
treatment [ftcn]
treatment [ftcn]
Group [idcn]
lowered [spco]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Acetate [orch, phsu]
Group [idcn]
Total Cholesterol [lbpr]
density [qnco]
Low density lipoprotein [aapp, bacs, lipd]
Triglyceride level [lbtr]
E2 [gngm]
Norethisterone acetate [horm, phsu, strd]
Group [idcn]
lowering [spco]
Total Cholesterol [lbpr]
Triglyceride level [lbtr]
magnitude [qnco]
serum concentration [qnco]
Total Cholesterol [lbpr]
Triglyceride [bacs, lipd]
treatment [ftcn]
Group [idcn]
Conclusions [idcn]
Continuous [idcn]
combined treatment [topp]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Acetate [orch, phsu]
E2 [gngm]
Norethisterone acetate [horm, phsu, strd]
lowered [spco]
Lp(a) [aapp, bacs]
Cardiovascular disease [dsyn]
Women [popg]
Treatments [topp]
effects [qlco]
Lipids [lipd]
Lipoproteins [aapp, bacs]
findings [ftcn]
interpret [ftcn]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
